The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Medikinet MR 30mg modified – release capsules, hard

Medice Arzneimittel Putter GmbH & Co. K.GPA1555/001/004

Main Information

Trade NameMedikinet MR 30mg modified – release capsules, hard
Active SubstancesMethylphenidate hydrochloride
Dosage FormModified-release capsule, hard
Licence HolderMedice Arzneimittel Putter GmbH & Co. K.G
Licence NumberPA1555/001/004

Group Information

ATC CodeN06BA Centrally acting sympathomimetics
N06BA04 methylphenidate


License statusAuthorised
Licence Issued20/05/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2). This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back